| ASHA | Action on Smoking and Health |
| CADTH | Canadian Agency for Drugs and Technologies in Health |
| CEAC | Cost-Effectiveness Acceptability Curve |
| CEAF | Cost-Effectiveness Acceptability Frontier |
| CRAN | Comprehensive R Archive Network |
| CrI | Credible Interval |
| DAG | Directed Acyclic Graph |
| EIB | Expected Incremental Benefit |
| EVPI | Expected Value of Perfect Information |
| EVPPI | Expected Value of Perfect Partial Information |
| GAM | Generalised Additive Model |
| GP | Gaussian Process |
| IB | Incremental Benefit |
| ICER | Incremental Cost-Effectiveness Ratio |
| INLA | Integrated Nested Laplace Approximation |
| MCMC | Markov Chain Monte Carlo |
| MLE | Maximum Likelihood Estimate |
| MTC | Mixed Treatment Comparison |
| NICE | National Institute for Health and Care Excellence |
| NHS | National Health Service |
| NMA | Network Meta-Analysis |
| NRT | Nicotine Replacement Therapy |
| OL | Opportunity Loss |
| ONS | Office for National Statistics |
| OTC | Over The Counter |
| PBAC | Pharmaceutical Benefits Advisory Committee |
| PSA | Probabilistic Sensitivity Analysis |
| QALY | Quality-Adjusted Life Year |
| RCT | Randomised Controlled Trial |
| SAVI | Sheffield Accelerated Value of Information |
| SPDE | Stochastic Partial Differential Equation |
| VBA | Visual Basic for Applications |
| VI | Value of Information |
| WTP | Willingness To Pay |